EUCTR2005-002250-21-IT进行中（未招募）不适用
EVALUATION OF ANTALGIC EFFECT AND TOLERABILITY OF A NEW PARACETAMOL SYRUP DOSAGE IN PHARINGOTONSILLYTIS IN PEDIATRY. DOUBLE-BLIND VS PLACEBO STUDY, CONTROLLED VS KETOPROFEN LYSINA SALT.
ANGELINI0 个研究点开始时间: 2005年6月28日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
尚未招募
3 期
Evaluation of the response and adverse effects of total neoadjuvant therapy (TNT) of advanced localized rectal cancerC18.7Rectal cancer.Malignant neoplasm of sigmoid colonIRCT20120215009014N431Hamedan University of Medical Sciences25
已完成
不适用
Comparative study of tolerability and efficacy of haloperidol versus olanzapine in schizophreniaCTRI/2015/02/005575Government Medical College and Hospital40
进行中（未招募）
1 期
Imiquimod versus PDT for actinic keratoses in in organ transplant recipientsEUCTR2012-000263-24-ATMedizinische Universität Wien, Univ. Klinik f. Dermatologie30
进行中（未招募）
1 期
Phase 2b study evaluating efficacy, safety and tolerability of study drug called NGM282 (Aldafermin) in Patients with Compensated Cirrhosis Due to Nonalcoholic SteatohepatitisCompensated Cirrhosis Due to Nonalcoholic SteatohepatitisMedDRA version: 22.0Level: PTClassification code 10053219Term: Non-alcoholic steatohepatitisSystem Organ Class: 10019805 - Hepatobiliary disordersMedDRA version: 20.1Level: LLTClassification code 10064844Term: Compensated cirrhosisSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2019-002341-38-FRGM Biopharmaceuticals, Inc.150
已完成
不适用
study on low back paiCTRI/2016/10/007348Dr Reddys Laboratories Pvt Ltd